Stockreport

BioTime Announces Issuance of U.S. Patent for Method of Reducing Cavitation in Patients with Acute Spinal Cord Injury

BlackRock Technology and Private Equity Term Trust Common Shares of Beneficial Interest  (BTX) 
NASDAQ:AMEX Investor Relations: biotimeinc.com/pexservice/investors
PDF ALAMEDA, Calif.--(BUSINESS WIRE)-- BioTime, Inc. (NYSE American and TASE: BTX), a clinical-stage biotechnology company developing cellular therapies f [Read more]